Michael Long
Hematology & Oncology · Mesa, AZNPI 1447224050
Payments from drug & device makers
Across 176 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$380
- Astellas Pharma US Inc$200
- Merck$139
- Bristol Myers Squibb$138
- Amgen$133
- AstraZeneca$128
- plus $2K from 33 others
What the payments were for
- Food & beverage$2,60798%
- Education$502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 41 | $380 |
| Astellas Pharma US Inc | 10 | $200 |
| Merck | 8 | $139 |
| Bristol Myers Squibb | 7 | $138 |
| Amgen | 8 | $133 |
| AstraZeneca | 8 | $128 |
| Aurobindo Pharma USA, Inc. | 3 | $128 |
| Novartis | 9 | $127 |
| Rigel Pharmaceuticals, Inc. | 7 | $118 |
| Daiichi Sankyo Inc. | 7 | $112 |
| E.r. Squibb & Sons, L.L.C. | 9 | $102 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $97 |
| Puma Biotechnology, Inc. | 5 | $87 |
| Clovis Oncology, Inc. | 5 | $65 |
| Ipsen Biopharmaceuticals, Inc | 4 | $64 |
| Sanofi | 4 | $59 |
| Gilead(2 entities) | 3 | $50 |
| Pfizer | 4 | $45 |
| Genentech USA, Inc. | 3 | $40 |
| AbbVie | 2 | $38 |
| EMD Serono, Inc. | 2 | $35 |
| GSK | 2 | $34 |
| Incyte Corporation | 2 | $32 |
| Array Biopharma Inc | 2 | $31 |
| Eisai Inc. | 2 | $26 |
| Boehringer Ingelheim | 1 | $24 |
| Seagen Inc. | 1 | $23 |
| Epizyme, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Dova Pharmaceuticals | 1 | $19 |
| Bayer | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $13 |
| CSL Behring | 1 | $12 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Folotyn$103
How this compares
$2,657 in reported general payments places this provider in the 25th percentile of 261 hematology & oncology providers in Arizona.
Other hematology & oncology in Mesa
- Chad CheringtonMesa$781K
- Tanios Bekaii-SaabScottsdale$31.4M
- Yousef ZakhariaScottsdale$13M
- Jiaxin NiuGilbert$10.7M
- Sudhir MandaTucson$10M
- Parminder SinghScottsdale$9.7M
- Michael GordonScottsdale$9.2M
- Mikhail ShtivelbandChandler$9.1M
- Daniel AhnScottsdale$9.1M
- Javier MunozPhoenix$8.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.